Literature DB >> 11052813

Stimulatory effects of cartilage-derived morphogenetic proteins 1 and 2 on osteogenic differentiation of bone marrow stromal cells.

R Gruber1, C Mayer, W Schulz, W Graninger, M Peterlik, G Watzek, F P Luyten, L Erlacher.   

Abstract

Cartilage-derived morphogenetic proteins 1 and 2 (CDMP-1 and CDMP-2) are members of the bone morphogenetic protein (BMP) family which play an important role in embryonic skeletal development. Throughout adult life, bone marrow-derived precursor cells maintain their ability to differentiate into osteoblasts in response to local growth factors. This study examines the osteogenic potential of CDMP-1, CDMP-2, BMP-6 and osteogenic protein 1 (OP-1) in bone marrow stromal cells (BMSC) and investigates the endogenous expression of CDMPs/BMPs and their respective activin receptor-like kinase (ALK) receptors. A 4-day exposure of BMSC to CDMP-1, CDMP-2, BMP-6, and OP-1 under serum-free conditions stimulated the progression of the osteogenic lineage in a dose-dependent manner as evaluated by alkaline phosphatase activity and osteocalcin synthesis. In contrast to the BMPs, CDMP-1 and especially CDMP-2 were significantly less osteogenic, as confirmed by Northern blot analysis. Moreover, BMSC were shown to express endogenously CDMP-2, BMP-2 to -6 and ALK-1, -2, -3, -5 and -6. Phenotypic characterization of BMSC by RT-PCR showed transcripts of the fat marker adipsin and the prechondrocytic marker procollagen type IIA; however, we were unable to detect the mature cartilage markers, procollagen type IIB and aggrecan, even after growth factor treatment. Our data indicate that CDMP-1, CDMP-2, BMP-6 and OP-1 enhance the osteogenic phenotype in BMSC, with CDMPs being clearly less osteogenic than BMPs. The endogenous expression of a variety of CDMPs/BMPs and their respective ALK receptors, suggests a possible involvement of these growth factors in the osteogenic differentiation of bone marrow progenitor cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052813     DOI: 10.1006/cyto.2000.0760

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

1.  Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells.

Authors:  Pit Jacob Voss; Akihiko Matsumoto; Esteban Alvarado; Rainer Schmelzeisen; Fabian Duttenhöfer; Philipp Poxleitner
Journal:  Odontology       Date:  2017-02-20       Impact factor: 2.634

2.  Calcitonin gene-related peptide stimulates proliferation and osteogenic differentiation of osteoporotic rat-derived bone mesenchymal stem cells.

Authors:  Wei Liang; Xianglong Zhuo; Zhongfei Tang; Xiaomou Wei; Bing Li
Journal:  Mol Cell Biochem       Date:  2015-01-07       Impact factor: 3.396

3.  BMP7 can promote osteogenic differentiation of human periosteal cells in vitro.

Authors:  Kangsheng Bei; Zhipo Du; Yinghui Xiong; Jiacheng Liao; Baojin Su; Liyang Wu
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

4.  Delayed fracture healing in growth differentiation factor 5-deficient mice: a pilot study.

Authors:  Cynthia M Coleman; Brooke H Scheremeta; Amanda T Boyce; Robert L Mauck; Rocky S Tuan
Journal:  Clin Orthop Relat Res       Date:  2011-05-18       Impact factor: 4.176

Review 5.  Available Findings Fail to Provide Strong Evidence of the Role of Bone Morphogenic Protein-2 in Femoral Head Osteonecrosis.

Authors:  Ali Parsa; Hamed Vahedi; Karan Goswami; Arash Aalirezaie
Journal:  Arch Bone Jt Surg       Date:  2020-01

Review 6.  Cartilage morphogenetic proteins: role in joint development, homoeostasis, and regeneration.

Authors:  A H Reddi
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 7.  Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head.

Authors:  Lars Rackwitz; Lars Eden; Stephan Reppenhagen; Johannes C Reichert; Franz Jakob; Heike Walles; Oliver Pullig; Rocky S Tuan; Maximilian Rudert; Ulrich Nöth
Journal:  Stem Cell Res Ther       Date:  2012-02-22       Impact factor: 6.832

8.  BMP-13 emerges as a potential inhibitor of bone formation.

Authors:  Bojiang Shen; Divya Bhargav; Aiqun Wei; Lisa A Williams; Helen Tao; David D F Ma; Ashish D Diwan
Journal:  Int J Biol Sci       Date:  2009-02-13       Impact factor: 6.580

Review 9.  Unveiling the bmp13 enigma: redundant morphogen or crucial regulator?

Authors:  Lisa A Williams; Divya Bhargav; Ashish D Diwan
Journal:  Int J Biol Sci       Date:  2008-09-11       Impact factor: 6.580

10.  A modified aggregate culture for chondrogenesis of human adipose-derived stem cells genetically modified with growth and differentiation factor 5.

Authors:  Xinlin Yang; Hulan Shang; Adam Katz; Xudong Li
Journal:  Biores Open Access       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.